TG Therapeutics, Inc. (TGTX)
USD 31.07
(-7.46%)
USD 31.07
(-7.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 233.66 Million | 2.78 Million | 6.68 Million | 152 Thousand | 152 Thousand | 152 Thousand |
| Cost of Revenue | 14.55 Million | 265 Thousand | 790 Thousand | 374 Thousand | 282 Thousand | 88 Thousand |
| Gross Profit | 219.1 Million | 2.52 Million | 5.89 Million | -222 Thousand | -130 Thousand | 64 Thousand |
| Operating Expenses | 198.47 Million | 195.35 Million | 350.66 Million | 273.74 Million | 169.2 Million | 174.55 Million |
| Selling, General and Administrative Expenses | 122.28 Million | 83.23 Million | 152.13 Million | 121.81 Million | 20.83 Million | 20.75 Million |
| Research and Development Expenses | 76.19 Million | 112.12 Million | 198.53 Million | 151.93 Million | 148.36 Million | 153.79 Million |
| Other Expenses | - | 4.69 Million | 2.3 Million | 542 Thousand | 1.47 Million | 61 Thousand |
| Cost and Expenses | 213.02 Million | 195.62 Million | 351.45 Million | 273.74 Million | 169.2 Million | 174.55 Million |
| Operating Income | 20.63 Million | -192.83 Million | -344.77 Million | -273.59 Million | -169.05 Million | -174.4 Million |
| Interest Expense | 12.61 Million | 10.19 Million | 5.63 Million | 6.32 Million | 5.28 Million | 1.73 Million |
| Income Tax Expense | 390 Thousand | 5.49 Million | 7.45 Million | 6.49 Million | 6.47 Million | -918 Thousand |
| Earnings before Tax | 13.06 Million | -198.33 Million | -348.1 Million | -279.38 Million | -172.87 Million | -173.48 Million |
| Net Income | 12.67 Million | -203.83 Million | -355.55 Million | -285.87 Million | -179.34 Million | -173.48 Million |
| Earnings Per Share Basic | 0.09 | -1.51 | -2.69 | -2.48 | -2.03 | -2.30 |
| Earnings Per Share Diluted | 0.09 | -1.51 | -2.69 | -2.48 | -2.03 | -2.30 |
| Weighted Average Shares Outstanding | 141.95 Million | 135.41 Million | 132.22 Million | 115.33 Million | 88.36 Million | 75.46 Million |
| Weighted Average Shares Outstanding (Diluted) | 148.5 Million | 135.41 Million | 132.22 Million | 115.33 Million | 88.36 Million | 75.46 Million |
| Gross Margin | 0.94 | 0.90 | 0.88 | -1.46 | -0.86 | 0.42 |
| EBIT Margin | 0.11 | -67.56 | -51.20 | -1796.39 | -1102.53 | -1146.79 |
| Profit Margin | 0.05 | -73.19 | -53.15 | -1880.78 | -1179.91 | -1141.33 |
| EBITDA | 26.1 Million | -187.62 Million | -341.96 Million | -272.67 Million | -168.5 Million | -173.39 Million |
| Earnings Before Tax Margin | 0.09 | -69.24 | -51.54 | -1799.96 | -1112.20 | -1147.37 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 83.87 Million | 73.46 Million | 63.47 Million | 233.66 Million | 43.97 Million | 165.81 Million |
| Cost of Revenue | 9.34 Million | 8.37 Million | 5.52 Million | 14.55 Million | 7.94 Million | 3.5 Million |
| Gross Profit | 74.53 Million | 65.09 Million | 57.95 Million | 219.1 Million | 36.02 Million | 162.3 Million |
| Operating Expenses | 62.1 Million | 56.27 Million | 67.22 Million | 198.47 Million | 48.51 Million | 47.52 Million |
| Selling, General and Administrative Expenses | 41.96 Million | 38.71 Million | 34.49 Million | - | 31.06 Million | 26.5 Million |
| Research and Development Expenses | 20.13 Million | 17.55 Million | 32.72 Million | - | 17.44 Million | 11.83 Million |
| Other Expenses | - | 1.71 Million | 880 Thousand | 5.04 Million | 890 Thousand | 9.18 Million |
| Cost and Expenses | 71.44 Million | 64.65 Million | 72.74 Million | 213.02 Million | 56.45 Million | 51.03 Million |
| Operating Income | 12.43 Million | 8.81 Million | -9.27 Million | 20.63 Million | -12.48 Million | 114.78 Million |
| Interest Expense | 10.83 Million | 3.97 Million | 2.28 Million | 12.61 Million | 2.43 Million | 3.71 Million |
| Income Tax Expense | 388 Thousand | -328 Thousand | 29 Thousand | 390 Thousand | 390 Thousand | -126 Thousand |
| Earnings before Tax | 4.26 Million | 6.55 Million | -10.67 Million | 13.06 Million | -14.02 Million | 113.93 Million |
| Net Income | 3.88 Million | 6.87 Million | -10.7 Million | 12.67 Million | -14.41 Million | 113.93 Million |
| Earnings Per Share Basic | 0.03 | 0.05 | -0.07 | - | -0.10 | 0.80 |
| Earnings Per Share Diluted | 0.02 | 0.04 | -0.07 | - | -0.10 | 0.73 |
| Weighted Average Shares Outstanding | 145.1 Million | 144.72 Million | 146.2 Million | 141.95 Million | 143.09 Million | 142.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 160.71 Million | 159.42 Million | 146.2 Million | 148.5 Million | 143.09 Million | 155.87 Million |
| Gross Margin | 0.89 | 0.89 | 0.91 | 0.94 | 0.82 | 0.98 |
| EBIT Margin | 0.18 | 0.12 | -0.14 | - | -0.28 | 0.69 |
| Profit Margin | 0.05 | 0.09 | -0.17 | 0.05 | -0.33 | 0.69 |
| EBITDA | 15.1 Million | 8.88 Million | -9.18 Million | - | -12.39 Million | 114.78 Million |
| Earnings Before Tax Margin | 0.15 | 0.12 | -0.15 | 0.09 | -0.28 | 0.69 |
VVY
MKC
IMM
002156
GLOSTERLTD
SHIP